Professional Documents
Culture Documents
Amphetamines & Sympathomimetic Amines-T NG-H P
Amphetamines & Sympathomimetic Amines-T NG-H P
2-(2,5-
Dimethoxy-4-
isopropylthiophen
yl)-N-[(2-
25T4- m/z →
18 methoxyphenyl)m 411.99 C21H29NO3S.HCl
1566-HC
ethyl]
ethanamine.hydro
chloride
4-Bromo-2,5-
21= ditrideuteromethox 2CB- m/z →
302.62 C10H8D6NO2Br.HCl
20 yphenethylamine.h 1596-HC
ydrochloride
4-Bromo-2,5-
2CB-
dimethoxyphenet C10H14NO2Br.HCl m/z →
22 729-HC 296.59
hylamine.hydroch
loride
4-Bromo-2,5-
23= dimethoxypheneth 2CB-729- 56281-37- m/z →
296.59 C10H14NO2Br.HCl
22 ylamine.hydrochlor HC 9
ide
2-(4-Chloro-2,5-
dimethoxy)ethana 2CC- 88441-15- m/z 216→184
24 252.14 C10H14ClNO2.HCl
169
mine.hydrochlori 1559-HC 0
de
2-(4-Chloro-2,5- 2CC-
25= 88441-15- m/z 216→184
dimethoxy)ethana 1559-HC 252.14 C10H14ClNO2.HCl
24 0 169
mine.hydrochloride
2-(4-Chloro-2,5-
26= 2CC- 88441-15- m/z 216→184
dimethoxy)ethana 252.14 C10H14ClNO2.HCl
24 1559-HC 0 169
mine.hydrochloride
4-Chloro-2,5-
ditrideuterometho 2CC- 951400- m/z →
27 258.17 C10H8D6ClNO2.HCl
xyphenethylamin 1597-HC 08-1
e.hydrochloride
4-Chloro-2,5-
28= ditrideuteromethox 2CC- 951400- m/z →
258.17 C10H8D6ClNO2.HCl
27 yphenethylamine.h 1597-HC 08-1
ydrochloride
4-Chloro-2,5-
29= ditrideuteromethox 2CC- 951400- m/z →
258.17 C10H8D6ClNO2.HCl
27 yphenethylamine.h 1597-HC 08-1
ydrochloride
2-(2,5-
Dimethoxy-4- 2CD-
25505-65- m/z 196→164
30 methyl)ethanamin 1553-HC 231.72 C11H17NO2.HCl
149
1
e.hydrochloride
2-(2,5-Dimethoxy-
31= 4- 2CD- 25505-65- m/z 196→164
231.72 C11H17NO2.HCl
30 methyl)ethanamine 1553-HC 1 149
.hydrochloride
1-(2,5-
Dimethoxy-4- 2CE-
71539-34- C12H19NO2.HCl m/z 210→178
32 ethylphenyl)-2- 1364- 245.74 91
9
aminoethane.hydr HC
ochloride
1-(2,5-Dimethoxy-
33= 4-ethylphenyl)-2- 2CE- 71539-34- m/z 210→178
245.74 C12H19NO2.HCl
32 aminoethane.hydr 1364-HC 9 91
ochloride
4-Iodo-2,5-
ditrideuterometho 2CI- m/z →
34 349.63 C10H8D6NO2I.HCl
xyphenethylamin 1587-HC
e.hydrochloride
4-Iodo-2,5-
35= ditrideuteromethox 2CI-1587- m/z →
349.63 C10H8D6NO2I.HCl
34 yphenethylamine.h HC
ydrochloride
4-Iodo-2,5-
2CI-740- 64584-32- C10H14NO2I.HCl m/z →
36 dimethoxyphenet 343.59
HC 3
hylamine.HCl
4-Iodo-2,5-
37= 2CI-740- 64584-32- m/z →
dimethoxypheneth 343.59 C10H14NO2I.HCl
36 HC 3
ylamine.HCl
2-(2,5-
Dimethoxy-4- 2CN- 261789- C10H14N2O4.HCl m/z 227→91
38 262.69 71
nitro)ethanamine. 1552-HC 00-8
hydrochloride
2-(2,5-Dimethoxy-
39= 4- 2CN- 261789- m/z 227.1→91.1
262.69 C10H14N2O4.HCl
38 nitro)ethanamine.h 1552-HC 00-8 →77.1
ydrochloride
2-(2,5-
m/z 224 →207.1
Dimethoxy-4-
40= 2CP- 1359704- →192.1
propylphenyl)etha 259.78 C13H21NO2.HCl
41 1551-HC 27-0
namine.hydrochlo
ride
39 2-(2,5-Dimethoxy- 2CN- 262.69 C10H14N2O4.HCl (+)
4- 1552-HC 261789- 227.1>91.1,77.1
nitro)ethanamine.h 00-8 (2.26p)
ydrochloride
54 AMP- (+)147>98
(±)-1-Phenyl-D5- 574-HC 182.73 C9H2D11N.HCl
1,1,2,3,3,3-
hexadeutero-2-
aminopropane
1,2-dideutero-1- 623-HC 1
phenyl-2-
propanamine.hydr
ochloride
57 (+)-2- AMP- 51-57-0 C10H15N.HCl (+) 150.1>91;119
Methylamino-2- 732-HC 185.70
phenylpropane.hyd
rochloride
58 (2R)-1-Phenyl- AMP-
3,3,3-trideutero- 817-SU 374.49 (C9H10D3N)2.H2SO4
propan-2-amine
sulfate
68 368.09 (C9H13N)2.H2SO4
1-Phenylpropan-2- AMP-95- 60-13-9
amine.(0.5 sulfate) SU
73 AMP- 205437-
(±)-1-Phenyl- 976-HC 60-1 177.70 C9H7D6N.HCl
1,1,2,3,3,3-
hexadeutero-2-
aminopropane
5-yl-butan-(1,2-
dideutero)-2-
amine.hydrochlorid
e
83 2-(Methylamino)- BUI- 215.72 C11H17NO.HCl
1-phenylbutan-1- 1473-HC
ol hydrochloride
84 2-(Methylamino)- BUI-
1-phenylbutan-1- 1473-HC 215.72 C11H17NO.HCl
ol hydrochloride
86 d-
Norpseudoephedri CAT-665- 2153-98-2 187.67 C9H13NO.HCl
ne hydrochloride HC
87 (RS)-1-(4-Amino- CBT- 21898-19- 313.65 C12H18Cl2N2O.HCl (+)
3,5- 1568-HC 1 277>203,132.04
dichlorophenyl)-
2-(tert-
butylamino)ethan
ol .hydrochloride
1-(2,5-
LC-MS/MS
Dimethoxyphenyl
DMA- 2801- 231. (+) m/z 196.1>
92 )propan-2- C11H17NO2.HCl
82-HC 68-5 72 121.0;91.0 [3]
amine.hydrochlori
2,5-DMA
de
2-(3,4- LC-MS/MS
Dimethoxyphenyl (+) m/z 196.1>
DMA- 120-26- 231.
93 )propylamine.hydr C11H17NO2.HCl 136.0;151.0;179.1
882-HC 3 72
ochloride [15]
3,4-DMA
LC-MS/MC
d,l-4-bromo-2,5-
DOB- 29705- 310.6 (+) m/z 274.1>
94 dimethoxyampheta C11H16BrNO2.HCl
274-HC 96-2 3 178.1;135.1 [3]
mine.HCl
DOB
(1R,2S)-2-
LC-MS
Methylamino-1-
EPH- 201. (+) m/z 166> 133;
95 phenyl-1- 50-98-6 C10H15NO.HCl
661-HC 70 115 [6]
propanol.hydrochl
Ephedrine
oride
LC-MS/MC
(+)-(1S,2S)-2- (+) m/z 166> 148;
EPH- 165.
96 Methylamino-1- 90-82-4 C10H15NO 133;117;91 [17]
775-FB 23
phenyl-1-propanol 1S,2S-(+)-
pseudoephedrine
(-)-(1R,2R)-2-
EPH- 321-97- 165.
98 Methylamino-1- C10H15NO
776-FB 1 23
phenyl-1-propanol
(1S,2R)-2-
Trideuteromethyla
mino-1-phenyl-1- EPH- 204.
99 C10H12D3NO.HCl
propanol.hydrochl 845-HC 71
oride
(1S,2R)-2-
Methylamino-1-
EPH- 24221- 202.
100 phenyl-1- C10H15NO.HCl
888-HC 86-1 54
propanol.hydrochl
oride
d,l-Ethyl 2-phenyl- LC-MS/MS
2-piperidin-2- EPN- 19716- 283.8 (+) m/z 248.2>
100 C15H21NO2.HCl
ylacetate.hydrochlo 1599-HC 79-1 0 84.1; 56.1 [3].
ride
(±)-1-(4-
Ethylphenyl)-2- ETE-
229. C12H19NO.HCl
101 methylamino-1- 1405-
75
propanol.hydrochl HC
oride
(RS)-N-Ethyl-1-[3-
(trifluoromethyl)ph
FEF-872- 404-82- 267.7
102 enyl]propan-2- C12H16F3N.HCl
HC 0 2 Dexfenfluramine
amine.
hydrochloride
(±)-1-(4-
Fluorophenyl)-2-
FEP- 219.6
103 methylamino-1- C10H14FNO.HCl
1456-HC 8
propanol.hydrochlo
ride
1,3-dimethyl-7-(2-
(1-phenylpropan-2- GC-MS
ylamino)ethyl)purin FNT- 1892- 377.8 m/z 341> 207;
105 C18H23N5O2.HCl
e-2,6- 1098-HC 80-4 7 250;322 [13]
dione.hydrochlorid Fenethylline
e
1,3-Dimethyl-7-[2-
(1-phenyl-3,3,3-
trideuteromethylpr
FNT- 380.8 C18H20D3N5O2.HC
106 opan-2-
1134-HC 9 l
ylamino)ethyl]purin
e-2,6-dione
hydrochloride
LC-MS
3-(1,3-Benzodioxol-
(+) m/z 208.1>
5-yl)-N,2-
HLM- 243.7 177.1;147.1;135;77
107 dimethylpropan-1- C12H17NO2.HCl
1404-HC 3 [14]
amine.hydrochlorid
MDMA methylene
e
homolog
d,l-4-Hydroxy-3- (+) m/z 182>
HMA-85- 13062- 217.7
108 methoxyamphetam C10H15NO2.HCl 165;133 [8]
HC 61-8 0
ine.hydrochloride HMA
d,l-4-Hydroxy-3- LC-MS
methoxymethamph HMM- 438625- 231.7 (+) m/z 196>
109 C11H17NO2.HCl
etamine.hydrochlori 417-HC 58-2 2 165;137 [7]
de HMMA
d,l-1-
Benzo[1,3]dioxol-5- LC-MS/MS
yl-N-methyl-butan- MBD- 103818- 243.7 m/z 208.1>177.1;
110 C12H17NO2.HCl
2- 193-HC 37-7 3 135.1 [5]
amine.hydrochlorid MBDB
e
d,l-1-
benzo[1,3]dioxol-5-
yl-N- LC-MS/MS
trideuteromethyl- MBD- 248.7 (+) m/z 213.2>
111 C12H12D5NO2.HCl
butan-(1,2- 571-HC 6 179.1; 136.1 [3].
dideutero)-2- MBDB-d5
amine.hydrochlorid
e
1-(1,3-Benzodioxol- LC-MS
5-yl)propan-2- MDA-79- 6292- 215.6 (+) m/z 180>
112 C10H13NO2.HCl
amine.hydrochlorid HC 91-7 8 163;135 [7]
e MDA
1-(3,4-
Methylendioxyphen LC-MS/MS
yl)-2-(1,2,3,3,3- MDA- 220.7 (+) m/z 185.1>
113 C10H8D5NO2HCl
pentadeuteropropa 927-HC 1 168.1;138.1 [3]
namine). MDA-d5
hydrochloride
1-(1,3-Benzodioxol-
GC-MS
5-yl)-N-ethyl-
MDE- 74341- 243.7 m/z 207> 72;
114 propan-2- C12H17NO2.HCl
191-HC 78-9 3 116;144 [13]
amine.hydrochlorid
e
d,l-3,4-
Methylenedioxyeth MDE- 248.7
115 C12H12D5NO2.HCl
ylamphetamine- 734-HC 7
D5.HCl
d,l-N-
trideuteromethyl-
3,4- MDM- 232.7
116 C11H12D3NO2.HCl
Methylenedioxymet 140-HC 3
hamphetamine
hydrochloride
(RS)-1-(Benzo[d]
[1,3]dioxol-5-yl)-N- LC-MS/MS
trideuteromethyl- (+) m/z 199.1>
MDM- 234.7
117 1,2-dideutero- C11H10D5NO2.HCl 165.1;135.1 [3]
324-HC 4
propan-2- MDMA-d5
amine.hydrochlorid
e
(RS)-1-(Benzo[d]
LC-MS/MS
[1,3]dioxol-5-yl)-N-
MDM- 64057- 229.7 (+) m/z 194.1>
118 methylpropan-2- C11H15NO2.HCl
94-HC 70-1 0 163.0;105.1 [3]
amine.
MDMA
hydrochloride
(±)-1-(4-
Methylphenyl)-2-
MEE- 229.7
119 ethylamino-1- C12H19NO.HCl
1455-HC 5
propanol.hydrochlo
ride
2-(3,4,5- LC-MS/MS
trimethoxyphenyl)e MES- 832-92- 247.7 (+) m/z 212.3>
121 C11H17NO3.HCl
thanamine.hydrochl 203-HC 8 3 180.3 [16]
oride Mescaline
1,3- LC-MS
MHA- 13803- 151.6
122 Dimethylamylamine C7H17N.HCl (+) m/z 116> 57;
1550-HC 74-2 8
.hydrochloride 43 [6]
1-(Thiophen-2-yl)- LC-MS/MS
2- MPA- 7464- 191.7 (+) m/z 156>
123 C8H13NS.HCl 58;97;125 [12].
methylaminopropa 1600-HC 94-0 2
MPA
ne.hydrochloride
LC-MS/MS
(+) m/z 234.1>
(±)-Methyl 2- 84.1; 56.1 [3].
phenyl-2-piperidin- MPH- 298-59- 269.7 LC-MS/MS
124 C14H19NO2.HCl
2-ylacetate 1043-HC 9 6 (+) m/z 234.15>
hydrochloride 149.02; 129.07;
84.08 [4].
Methylphenidate
d,l-threo-Methyl 2-
phenyl-2-
monodeutero-2-(2-
MPH- 279.8
125 nonadeuteropiperi C14H9D10NO2.HCl
1675-HC 3
dyl)
acetate.hydrochlori
de
1-[4- LC-MS/MS
(Methylthio)phenyl] 14116- (+) m/z 182.1>
MTA- 217.7
126 propan-2- 06-4 C10H15NS.HCl 165.1;123.1;137.0
730-HC 6
amine.hydrochlorid (FB) [11]
e 4-MTA
(±)-1-(4-
Methylphenyl)-2-
MTE- 215.7
128 methylamino-1- C11H17NO.HCl
1406-HC 2
propanol.hydrochlo
ride
(±)-5-(4-
LC-MS/MS
Chlorophenyl)-3,5-
MZD- 22232- 284.7 (+) m/z 285.3>43.8
130 dihydro-2H- C16H13ClN2O
1274-FB 71-9 4 [2]
imidazo[2,1-
Mazindol
a]isoindol-5-ol
LC-MS
2-(2-Aminoethyl)-
(+) m/z 304>287;
3-(4-chlorophenyl)-
MZD- 13473- 339.2 285.1 [18]
131 3- C16H15ClN2O2.HCl
1812-HC 53-5 2 Metabolite of
hydroxyphthalimidi
ne. hydrochloride Mazindol
LC-MS/MS
(±)-2-Amino-1-
NOR- 154-41- 187.6 (+) m/z 152>
132 phenyl-1-propanol C9H13NO.HCl
662-HC 6 7 134;117;91[17]
hydrochloride
Norephedrine
LC-MS/MS
(RS)-2-Amino-5-
PEM- 176.1 m/z 176>107;
133 phenyl-1,3-oxazol- C9H8N2O2
541-FB 7 90;89;77 [10]
4(5H)-one
Pemoline
GC-MS
1-Amino-2- PHA-
156-28- 157. C8H11N.HCl m/z 121>91;77;30
134 phenylethane.hydr 883-HC
5 64 [5]
ochloride
PEA
2-Benzylpropan-
1,1,1,3,3,3-D6-2- PHE- 126139 191.7
135 C10H9D6N.HCl
amine.hydrochlorid 1770-HC 5-67-8 3
e
2-Methyl-1- LC-MS/MS
phenylpropan-2- PHE- 1197- 185.6 (+) m/z 150.1>
136 C10H15N.HCl
amine.hydrochlorid 844-HC 21-3 9 133.1;91.0[11]
e Phentermine
1-(4-
LC-MS/MS
methoxyphenyl)-
PMA- 52740- 201.7 (+) m/z 166.1>
137 propan-2- C10H15NO.HCl
619-HC 56-4 0 149.1; 121.1 [3].
amine.hydrochlorid
PMA
e
1-(4-
LC-MS/MS
Methoxyphenyl)-N-
PMM- 3398- 215.7 (+) m/z 180.1>
138 methyl-propan-2- C11H17NO.HCl
621-HC 68-3 2 121;91.1 [3]
amine.hydrochlorid
PMMA
e
2-Phenyl-2-
RTN- 19395- 255.7
139 piperidin-2-ylacetic C13H17NO2.HCl
1676-HC 40-5 4
acid.hydrochloride
d,l-threo-2-Phenyl-
2-monodeutero-2-
(2- RTN- 265.8
140 C13H7D10NO2.HCl
nonadeuteropiperi 1677-HC 1
dyl) acetic
acid.hydrochloride
2-(Hydroxymethyl)-
LC-MS/MS
4-[1-hydroxy-2-
SAL-117- 18559- 239.3 m/z 240.1>148.1
141 (tert- C13H21NO3
FB 94-9 2 [9]
butylamino)ethyl]p
Salbutamol
henol
[1] Mohamed, D., Hassan, O., Bahnasawy, N., Elnoby, A. S., & Mowaka, S. (2019). UPLC-MS/MS estimation of paracetamol, pseudoephedrine
hydrochloride and brompheniramine maleate in plasma: Application to a pharmacokinetic study on healthy Egyptian volunteers based on ethnic
difference. Microchemical Journal, 150, 104146. doi:10.1016/j.microc.2019.104146
[2] Kim, S.-S., Lee, H.-W., & Lee, K.-T. (2009). Validated method for determination of mazindol in human plasma by liquid
chromatography/tandem mass spectrometry. Journal of Chromatography B, 877(10), 1011–1016. doi:10.1016/j.jchromb.2009.02.049
[3] Lehmann, S., Kieliba, T., Beike, J., Thevis, M., & Mercer-Chalmers-Bender, K. (2017). Determination of 74 new psychoactive substances in
serum using automated in-line solid-phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Chromatography B, 1064,
124–138. doi:10.1016/j.jchromb.2017.09.003.
[4] https://scholar.sun.ac.za/bitstream/handle/10019.1/109098/tiya_toxicology_2020.pdf?sequence=1.
[5] TAKAHASHI, M., NAGASHIMA, M., SUZUKI, J., SETO, T., YASUDA, I., & YOSHIDA, T. (2009). Creation and application of
psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas
chromatography–mass spectrometry. Talanta, 77(4), 1245–1272. doi:10.1016/j.talanta.2008.07.062.
[6] Kerpel dos Santos, M., Gleco, E., Davidson, J. T., Jackson, G. P., Pereira Limberger, R., & Arroyo, L. E. (2018). DART-MS/MS screening
for the determination of 1,3-dimethylamylamine and undeclared stimulants in seized dietary supplements from Brazil. Forensic Chemistry, 8,
134–145. doi:10.1016/j.forc.2018.03.005.
[7] Shima, N., Katagi, M., Kamata, H., Zaitsu, K., Kamata, T., Nishikawa, M., … Nemoto, N. (2008). Urinary excretion of the main metabolites
of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in
humans and rats. Xenobiotica, 38(3), 314–324. doi:10.1080/00498250701802506.
[8] Forsling, M. L., Fallon, J. K., Shah, D., Tilbrook, G. S., Cowan, D. A., Kicman, A. T., & Hutt, A. J. (2002). The effect of 3,4-
methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat
hypothalamus. British Journal of Pharmacology, 135(3), 649–656. doi:10.1038/sj.bjp.0704502.
[9] download (psu.edu).
[10] Hess, C., Ritke, N., Sydow, K., Mehling, L.-M., Ruehs, H., Madea, B., & Musshoff, F. (2014). Determination of levamisole, aminorex, and
pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a pharmacokinetic study of levamisole. Drug
Testing and Analysis, 6(10), 1049–1054. doi:10.1002/dta.1619.
[11] Decaestecker, T., De Letter, E., Clauwaert, K., Bouche, M. P., Lambert, W., Van Bocxlaer, J., … De Leenheer, A. (2001). Fatal 4-MTA
Intoxication: Development of a Liquid Chromatographic-Tandem Mass Spectrometric Assay for Multiple Matrices. Journal of Analytical
Toxicology, 25(8), 705–710. doi:10.1093/jat/25.8.705.
[12] Camuto, C., Pellegrini, S., De‐Giorgio, F., Torre, X., Marti, M., Mazzarino, M., & Botrè, F. (2020). Urinary excretion profile of
methiopropamine in mice following intraperitoneal administration: a liquid chromatography‐tandem mass spectrometry investigation. Drug
Testing and Analysis. doi:10.1002/dta.2900.
[13] Mohamed, K. (2017). One-Step Derivatization-Extraction Method for Rapid Analysis of Eleven Amphetamines and Cathinones in Oral
Fluid by GC–MS. Journal of Analytical Toxicology, 41(7), 639–645. doi:10.1093/jat/bkx046.
[14] Liu, C., Jia, W., Qian, Z., Li, T., & Hua, Z. (2016). Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB,
MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe. Drug Testing and Analysis, 9(2), 199–207. doi:10.1002/dta.1955.
[15] Caspar, A. T., Meyer, M. R., Westphal, F., Weber, A. A., & Maurer, H. H. (2018). Nano liquid chromatography-high-resolution mass
spectrometry for the identification of metabolites of the two new psychoactive substances N- ( ortho -methoxybenzyl)-3,4-
dimethoxyamphetamine and N- ( ortho -methoxybenzyl)-4-methylmethamphetamine. Talanta, 188, 111–123. doi:10.1016/j.talanta.2018.05.064.
[16] Тяло (researchgate.net).
[17] Sørensen, L. K. (2011). Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography–
electrospray tandem mass spectrometry. Journal of Chromatography B, 879(11-12), 727–736. doi:10.1016/j.jchromb.2011.02.010.
[18] De Oliveira, M. H., Carlos, G., Bergold, A. M., Pechansky, F., Limberger, R. P., & Fröehlich, P. E. (2014). Determination of mazindol in
human oral fluid by high performance liquid chromatography-electrospray ionization mass spectrometry. Biomedical Chromatography, 28(8),
1064–1069. doi:10.1002/bmc.3120.
[19]